MONITORING AND EVALUATION FRAMEWORK FOR THE …

1 MONITORING AND EVALUATION FRAMEWORK FOR THE COVID-19 RESPONSE IN THE WHO AFRICAN REGIONA ugust 2020 MONITORING and EVALUATION FRAMEWORK for the Covid-19 response in the WHO African RegionISBN: 978-929023443-2 WHO Regional Office for Africa 2020 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike IGO licence (CC BY-NC-SA IGO; ). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services.

2 The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition . Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation.

3 MONITORING and EVALUATION FRAMEWORK for the Covid-19 response in the WHO African Region. Brazzaville: WHO Regional Office for Africa; 2020. Licence: CC BY-NC-SA IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at Sales, rights and licensing. To purchase WHO publications, see To submit requests for commercial use and queries on rights and licensing, see Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

4 General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

5 All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Designed and printed in the WHO Regional Office for Africa, Brazzaville, Congo2 TABLE OF CONTENT03 Foreword04 List of Acronyms05 Introduction06 Target Audience 07 Aims and Objectives08 M&E Logical FRAMEWORK and Performance-Based Results10 International Partners11 Operationalization.

6 M&E System Approach11 human Resources, Roles and Responsibilities 11 Workflow Data Collection, Data Sources and Data processing 13 Data Analysis and Synthesis13 Communication and Use, Report Writing14 National Repository of Indicators, Tools, and Capacity-Building15 National Country Level Repository 15 Country Level Repository and WHO Traffic Light Approach 15 New Weekly Reporting Tool and KPIs15 Additional Tools: Risk Scoring and Composite/Index Indicators Capacity Building17 M&E of COVID-19 Response of the WHO Country and Regional Offices 18 Regional Level Repository and WHO Traffic Light Approach19 References20 Appendixppppppppppp pppppppppp3 ForewordSince the report of a cluster of unusual pneumonia cases in Wuhan, China in December 2019, caused by a novel coronavirus, SARS-CoV-2, COVID-19 has spread to nearly every country and territory in the world.

7 The disease arrived in Africa in February 2020, with initial cases introduced by travellers from Europe into Egypt and Algeria. As of 8 July 2020, there was a cumulative total of 395 024 cases and 7376 deaths reported from all countries in the WHO African Region. Globally, cases now exceed 11 million, with more than 500 000 deaths. Although the Region accounts for a small percentage of cases and even fewer deaths, the impact of COVID-19 has been late into the pandemic, the African Region has the benefit of learning from responses elsewhere in the world and progress has been made in tackling the virus, most notably the rapid increase in testing capacity, rising from two countries in February 2020 to more than 40 countries to date.

8 In addition, all countries rapidly implemented public health measures such as case finding, testing, contact tracing and isolation and quarantine, as well as targeted care for those requiring hospital admission. Non-pharmaceutical prevention measures, such as physical distancing, wearing of face masks and hand hygiene have been universally introduced. Most countries closed their borders and instituted lockdowns, closing businesses and schools, banning large gatherings and restricting people s movement. However, in the developing world context, these strict measures are economically unsustainable. Presently, most of the Region is resuming economic activity, even with rising numbers of cases, but maintaining non-pharmaceutical measures, and discouraging large gatherings and non-essential movement of introduction of the Transformation Agenda saw the implementation of a cross-cutting information management programme, feeding into all aspects of the Health Emergencies Programme, which has centralized the role of data collection, MONITORING and EVALUATION and accountability.

9 These data and information are widely used by ministries of health, partners and WHO to inform responses to outbreaks and M&E FRAMEWORK targets ministries of health, WHO country offices and the Regional Office, and aims to assess national, country and regional response performance and progress, measured against country national plans, response efforts and the broader WHO COVID-19 Strategic Preparedness and Response Plan. The FRAMEWORK presented here emphasizes a results-based performance approach, which requires systematic collection, analysis and reporting against a defined set of indicators for planned interventions in the 11 response pillars to ensure full MONITORING of a comprehensive response.

10 Well-known M&E standards are used to operationalize the FRAMEWORK human resources, data collectionand resources, processing , analysingand synthesizing, producingcommunications and reports. Anational repository of indicators isavailable in the M&E FRAMEWORK ,monitored using key performanceindicators. Additionally, there isa repository of indicators thatallows WHO to monitor its ownmandate and performance, as wellas its performance at country andregional levels using a traffic lightapproach .This investment in M&E will enhance data collection and the other roles of the information management programme to increase transparency and accountability for better results and outcomes. I urge all Member States, partners and WHO staff to use this strengthened M&E FRAMEWORK to successfully control the COVID-19 outbreak in the Region.